XII Medical Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Private

  • Employees
  • 36

Employees

  • Latest Deal Type
  • Series B

  • Latest Deal Amount
  • $45M

  • Investors
  • 10

XII Medical General Information

Description

Developer of an implantable neurostimulation device designed to alleviate sleep apnea. The company develops a minimally invasive outpatient technology that does not allow the muscles in the throat to temporarily relax, and avoids blockage of the airway during sleep, enabling patients to proactively increase oropharyngeal airflow.

Contact Information

Formerly Known As
Enhale Medical
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 32980 Alvarado Niles Road
  • Suite 854-856
  • Union City, CA 94587
  • United States
+1 (216)
Primary Industry
Therapeutic Devices
Corporate Office
  • 32980 Alvarado Niles Road
  • Suite 854-856
  • Union City, CA 94587
  • United States
+1 (216)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

XII Medical Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC (Series B) 21-Aug-2024 $45M Completed Generating Revenue
3. Later Stage VC (Series A1) Completed Generating Revenue
2. Later Stage VC (Series A) 29-Apr-2022 $22.6M $22.6M Completed Generating Revenue
1. Grant 08-Dec-2017 $150K Completed Generating Revenue
To view XII Medical’s complete valuation and funding history, request access »

XII Medical Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B
Series A-1
Series A 75,333,317 $0.000100 8% $0.3 $0.3 1x $0.3 24.24%
To view XII Medical’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

XII Medical Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of an implantable neurostimulation device designed to alleviate sleep apnea. The company develops a minimally
Therapeutic Devices
Union City, CA
36 As of 2025

Mont-Saint-Guibert, Belgium
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

XII Medical Competitors (1)

One of XII Medical’s competitors is Nyxoah, a Formerly VC-backed company based in Mont-Saint-Guibert, Belgium.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Nyxoah Formerly VC-backed Mont-Saint-Guibert, Belgium
You’re viewing 1 of 1 competitors. Get the full list »

XII Medical Patents

XII Medical Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026147954-A1 Neuromodulation systems and devices Pending 06-Jan-2025
US-20260061199-A1 Devices, systems, and methods for treating sleep disordered breathing Pending 05-Sep-2024
WO-2026035892-A1 Wireless power transfer Pending 08-Aug-2024
US-20250312600-A1 Neuromodulation devices and associated systems and methods Pending 03-Apr-2024
WO-2025212442-A1 Neuromodulation devices and associated systems and methods Pending 03-Apr-2024 A61N1/3606
To view XII Medical’s complete patent history, request access »

XII Medical Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

XII Medical Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds
Intuitive Ventures Corporate Venture Capital Minority
Omega Funds Venture Capital Minority
Ajax Health PE/Buyout Minority
Aperture Venture Partners Venture Capital Minority
Broadview Ventures Venture Capital Minority
You’re viewing 5 of 10 investors. Get the full list »

XII Medical FAQs

  • When was XII Medical founded?

    XII Medical was founded in 2017.

  • Where is XII Medical headquartered?

    XII Medical is headquartered in Union City, CA.

  • What is the size of XII Medical?

    XII Medical has 36 total employees.

  • What industry is XII Medical in?

    XII Medical’s primary industry is Therapeutic Devices.

  • Is XII Medical a private or public company?

    XII Medical is a Private company.

  • What is the current valuation of XII Medical?

    The current valuation of XII Medical is .

  • What is XII Medical’s current revenue?

    The current revenue for XII Medical is .

  • How much funding has XII Medical raised over time?

    XII Medical has raised $82.6M.

  • Who are XII Medical’s investors?

    Intuitive Ventures, Omega Funds, Ajax Health, Aperture Venture Partners, and Broadview Ventures are 5 of 10 investors who have invested in XII Medical.

  • Who are XII Medical’s competitors?

    Nyxoah is a competitor of XII Medical.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process